Nuevos tratamientos en los tumores neuroendocrinos gastroenteropancreáticos

The response of these tumors to conventional chemotherapy is limited. The development of studies with antiangiogenic drugs, epidermic growth factor receptor inhibitors, and mTOR inhibitors probably represents a significant advance in the treatment of neuroendocrine tumors.